Good morning,
We are in the process of developing a policy surrounding weight (specifically dosing weight) for our (pediatric) institution and was wondering if anyone has one already in use that they are willing to share?
Thank you,
Jordan Anderson
Driscoll Children's Hospital

Hi All,

Interested in dispensing process best practices for products that are drawn up in IV syringes that are not intended to be administered via IV route. For example, bladder irrigation solutions, inhaled pentamidine, alteplase for chest tube administration, etc.

We are evaluating our standards to determine if there is a need to require nurse pick up for these types of products referenced above. Of note, we have other safeguards in place including appropriate route of administration on MAR, auxiliary labeling "not for IV use", etc.

Hi All,

We are evaluating our current process of adding electrolyte replacement doses to 24hr supply of enteral formula in pediatric patients and are interested in the following:

1. Does your institution have pharmacy add enteral electrolyte replacements (e.g. NaCl, NaHCO3, etc) directly to 24 hour supply of formula to administer continuously? If so, what process is in place to handle appropriately?

Dear all,

For your automated dispensing cabinets (omnicell, pyxis, etc.), when a medication is overridden, do you ask a RN to enter a specific reason other than stat or emergency?

Thank you,
Deepika

USA Today article, for your awareness
https://www.usatoday.com/story/news/investigations/2023/10/26/pharmacy-c...

Hello,

I'm curious if any institutes which utilize repeater pumps for compounding have any experience or thoughts on the following:

- For repeater pumps with selectable flow rates, what is your institution's preferred setting (e.g., low, medium, high).?
- Have you noticed any variations in volumes when utilizing higher flow rates?
- What is your expected and/or tolerance for variation when utilizing repeater pumps?
- How frequently do you recalibrate your repeater pumps (e.g., daily, after a certain number of pumps, etc.)

Thank you,
T.J.

Does anyone use a process (committee approval vs decision tree vs expert opinion) for evaluating whether something should be built as a physical kit, virtual kit, or just stocked in an Omnicell?

Ideally, this looks like some sort of objective decision tree based on the situation you are evaluating, but hoping someone else might have built this before we explore it for our health system.

Thanks!

Hi all-- would you please let me know if you are requiring tele-monitoring for IV lacosamide? Thanks in advance.

For those hospitals who begun using Beyfortus for RSV season and procure your supply via Vaccine For Children program.
Do you know of any requirements for data transmission/collection/reporting back to the program. For vaccines it is easy, but Beyfortus is a monoclonal antibody with CVX code. Strange combination, struggling to find answers.
Thanks.

We recently had a situation where a patient adjusted the rate in the IV pump of a medication they were receiving. It is not standard practice to lock the programming of the IV pumps. Does anyone have standards on locking the programming of IV pumps or any guidance around that? Thanks.